MDisrupt Webinar Panel: Kevin Coker, Proxima Clinical Research's CEO, In a Panel Discussing, "How will regulation of digital health products be impacted with the new administration?"
With the transition to the Biden-Harris Administration, appointing new leadership within the healthcare focused agencies, and the swearing in of the new Congress, the precision medicine industry can expect new attention to critical policy issues including regulation of diagnostic testing, digital health platforms, and at home testing. Is your regulatory team prepared for these changes?
In this webinar, we will cover:
Access the webinar, here.